company? Let’s change
that.
Stern Investor Relations is a premier investor relations firm, representing biotechnology companies across all market capitalizations and stages of development, and offering strategic and client-specific advisory services. For more information, email [email protected] or visit our website at www.sternir.com
Our mission is to fight cancer cooperatively instead of individually by connecting scientists and pathologists for online collaboration. HistoWiz provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise. The web-based platform accelerates information exchange among scientists, pathologists, and everyday people who are interested in learning more about a certain type of cancer.
Life sciences and biotechnology company with a mission to help people to heal. Working with leading hospitals and universities on developing evidence based clinical nutrition products to enhance patient outcomes. We're very proud to have earned the trust of some of the most demanding and discerning clients in medicine, US special forces and professional sports
BrainCheck is a mobile interactive test for cognitive health.
At Phosphorus, our mission is to extend and improve lives by making genomics a foundational part of everyone’s health and wellness journey. We have built a verticalized genetic testing platform, from wet lab chemistry to software and bioinformatics, allowing us to provide the most comprehensive, medical-grade genetic tests at price points helping to democratize access to genomic information. We seek to partner with and empower healthcare providers to make preventative genomics the norm in medicine.
We create and apply bold new thinking that makes a difference for patients, for our communities, and for our people. We are driving forward new ideas, innovation, testing and the development of new digital products and services to support patients, researchers, and clinicians.
PWNHealth is a national clinician network serving all 50 states and Puerto Rico with telehealth and telegenetic services. Our model enables safe and easy access to diagnostic testing. Our solutions provide the clinical, legal, and technological framework to facilitate large-scale consumer testing across key healthcare markets.
Scismic is a tech platform built by scientists to help biotechs grow qualified and diverse scientific teams. Our specialized algorithm accurately targets relevant candidates for faster hiring. We are funded by the NIH to reduce bias in candidate evaluation through our gender- and race-blind skills matching technology, so you can hire scientists from all walks of life with the skills you need.
Lokavant is a clinical intelligence platform that improves the time, cost, and quality of trial execution through data-driven analytics applications. Lokavant’s platform aggregates and integrates real-time data from disparate trial data sources, and powers advanced analytics enabled by its compendium of proprietary trial data. The suite of applications built on the platform allows study teams to proactively manage their studies, and surfaces insights, driving efficiencies in all scientific and operational use cases. For more information, please visit www.lokavant.com.
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Since 2013, Lightmatter has built digital products for all kinds of founders, teams, and industries. Building is intoxicating. It's core to our DNA. As we've grown, we noticed that the work we were most proud of, the work that had the greatest impact on others, was in health. Our clients were building products to solve problems we've all experienced as patients: broken telehealth portals, apps that neglected usability, and software that compromised PHI. Covid heightened just how inadequate these digital health experiences are when we’ve needed them most. We've narrowed our focus to health because the digital products we build can have an immediate impact on the health, wellness, and HCIT companies we serve...and the patients that they serve. To make any meaningful change in the world, we have to take care of the humans in it.
Tatch is transforming sleep diagnostics by shrinking an entire sleep lab to a single wearable patch. Our platform delivers consumer comfort with clinical performance by using cutting-edge sensor design, a cloud-native suite of state-of-the-art algorithms and a sleek mobile app, creating a seamless experience for both patient and doctor.
Melonfrost has created a novel way to modify living things. By combining machine learning and evolutionary biology, our Maia™ software can steer the evolution of organisms in real-time. Our platform, which includes our proprietary Evolution Reactor™, is the dawn of the next generation of biotechnology tools - allowing us to more efficiently solve problems in therapeutics, biomaterials, food, and energy.
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape. Founded in 2022 by Population Health Partners and ARCH Venture Partners, Metsera has raised $290 million in financing from leading healthcare investors and is based in New York City.
BenevolentAI is the global leader in the development and application of artificial intelligence (“AI”) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world’s 8,000 untreated diseases.
Flywheel is a creative agency that supports top healthcare companies with strategic consulting and innovative marketing and training services. Our clients are pharmaceutical, medical device, and biotech ventures that seek more effective engagement with their customers - and we help them make that happen.
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click’s platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. NOTE: Fake job advertisements and offers are increasingly appearing on the internet. If you have encountered a job posting or have been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond and report it to the Federal Trade Commission and to [email protected]. Other than your email address or telephone number, which you may provide via a job application portal, Click Therapeutics will never ask you to provide personally identifiable information about yourself (such as a Social Security Number or Driver’s License Number) via a messaging application.
Helaina is a VC-backed biotech startup creating a new category of functional food products. We're the first company to put human proteins into food, starting with making the most human-like infant formula in order to empower and equip parents with more choice in their infant’s nutrition. Helaina’s R&D harnesses the power of naturally occurring biological processes in tandem with modern advances in the space of synthetic biology, fermentation, and improved industrial processing. We developed a novel precision fermentation platform to unlock a suite of functional proteins, which allows us to create infant formula with health benefits previously only available through breast milk.
With a potential 60 percent increase in the number of cancer cases globally in the next two decades and a decrease in the number of pathologists relative to this diagnostic demand, the need to expedite advancements in pathology is pressing. This issue is further exacerbated by the fact that pathology — despite being the foundation of diagnosis — has yet to become digital. Led by a team of experts in pathology, machine learning, healthcare, and business, Paige strives to make it possible to not only provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and accurately, but also to go beyond this traditional work to extract new diagnostic information from pathology slides and patient samples that have the potential to support informed treatment pathways for patients. Paige technology is also helping life sciences companies evaluate and design personalized treatments for patients.
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, helping people live longer, healthier lives.